Table 2.
Comparison of the plasma markers between hypertension and control group.
| General population | Men | Women | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Control (n = 1135) | Hypertension (n = 1489) | P | Control (n = 436) | Hypertension (n = 669) | P | Control (n = 699) | Hypertension (n = 820) | P | |
| hs-CRP (mg/L) | 0.86(0.47–1.71) | 1.13(0.60–2.08) | <0.001 | 0.90(0.48–1.90) | 1.11(0.61–2.16) | 0.001 | 0.84(0.45–1.65) | 1.15(0.59–2.03) | <0.001 |
| Hcy (µmol/L) | 9.11(7.80–11.36) | 9.75(8.14–12.45) | <0.001 | 10.44(8.80–12.49) | 11.24(9.14–14.17) | <0.001 | 8.54(7.45–10.17) | 8.85(7.64–10.68) | 0.004 |
| NT-proBNP (ng/mL) | 49.57(30.12–77.49) | 51.32(31.37–87.57) | 0.096 | 43.05(24.98–73.27) | 44.59(26.53–79.39) | 0.360 | 54.50(34.41–80.09) | 57.89(36.55–91.93) | 0.034 |
| 25-OHD (nmol/L) | 13.74(9.92–18.63) | 14.16(9.80–19.85) | 0.168 | 16.23(11.65–23.01) | 16.74(12.25–22.52) | 0.356 | 12.46(8.89–16.64) | 12.13(8.49–16.94) | 0.733 |
| HBA1C (%) | 4.99(4.66–5.43) | 5.19(4.77–5.84) | <0.001 | 5.03(4.64–5.44) | 5.17(4.76–5.85) | <0.001 | 4.98(4.67–5.43) | 5.22(4.80–5.82) | <0.001 |
| hsTnT (ng/mL) | 7.75(5.65–10.05) | 8.04(6.01–10.36) | 0.027 | 8.53(6.27–11.35) | 9.17(6.73–11.84) | 0.104 | 7.24(5.31–9.25) | 7.26(5.55–9.50) | 0.438 |
| SUA (µmol/L) | 297.85(253.47–352.47) | 321.68(265.01–376.28) | <0.001 | 342.81(297.02–394.23) | 357.34(308.57–409.68) | 0.004 | 274.95(239.40–313.81) | 287.06(246.15–339.70) | <0.001 |
Note: Plasma markers are expressed as Median (25% quartiles–75% quartiles). hs-CRP = high-sensitivity C-reactive protein; hs-cTnT, high-sensitivity cardiac troponin T; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; 25OHD, 25-Hydroxyvitamin D; SUA, serum uric acid and HbA1c, glycosylated hemoglobin A1c.